1st Quarter - Report

CAPITOL HEALTH GROUP, LLC for AMERISOURCEBERGEN CORPORATION

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R.905 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.733 - A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.89 - Withholding Tax Relief Act of 2011 S.164 - Withholding Tax Relief Act of 2011 H.R.1483 - Drug Safety Enhancement Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.1584 - Drug Safety and Accountability Act of 2011 H.R.2245 - Preserving Access to Life-Saving Medications Act of 2011 S.296 - Preserving Access to Life-Saving Medications Act H.R.3630 - Temporary Payroll Tax Cut Continuation Act of 2011

LobbyistCovered position, as disclosed
CHELSEA ARNONE Temporary Employee, Congressman Fred Upton
MICHAEL BROMBERG —
SHAWN COUGHLIN —
JENNIFER HIGGINS —
STEVEN JENNING —

Contacted: Health & Human Services, Dept of (HHS); Agency for Healthcare Research & Quality (AHRQ); SENATE; Congressional Budget Office (CBO); Executive Office of the President (EOP); Office of Management & Budget (OMB); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); Government Accountability Office (GAO)

Bills named: H.R. 3630 (112th), H.R. 3026 (112th), S. 1584 (112th), H.R. 905 (112th), S. 733 (112th), S. 164 (112th), H.R. 1483 (112th), S. 89 (112th), H.R. 2245 (112th), S. 296 (112th)

Medicare/Medicaid MMM

H.R.905 - To amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.733 - A bill to amend part B of title XVIII of the Social Security Act to exclude customary prompt pay discounts from manufacturers to wholesalers from the average sales price for drugs and biologicals under Medicare. S.89 - Withholding Tax Relief Act of 2011 S.164 - Withholding Tax Relief Act of 2011 H.R.1483 - Drug Safety Enhancement Act of 2011 H.R.3026 - Safeguarding America's Pharmaceuticals Act of 2011 S.1584 - Drug Safety and Accountability Act of 2011 H.R.2245 - Preserving Access to Life-Saving Medications Act of 2011 S.296 - Preserving Access to Life-Saving Medications Act H.R.3630 - Temporary Payroll Tax Cut Continuation Act of 2011 ASP Generally (in the context of Deficit Reduction)

LobbyistCovered position, as disclosed
CHELSEA ARNONE Temporary Employee, Congressman Fred Upton
MICHAEL BROMBERG —
SHAWN COUGHLIN —
JENNIFER HIGGINS —
STEVEN JENNING —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Office of Management & Budget (OMB); Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Agency for Healthcare Research & Quality (AHRQ); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); Executive Office of the President (EOP); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 2245 (112th), S. 89 (112th), S. 733 (112th), S. 164 (112th), H.R. 3630 (112th), H.R. 1483 (112th), S. 1584 (112th), S. 296 (112th), H.R. 3026 (112th), H.R. 905 (112th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.